Cargando…
Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment
BACKGROUND: The increasing morbidity and mortality rates associated with Acinetobacter baumannii are due to the emergence of drug resistance and the limited treatment options. We compared characteristics of colistin-resistant Acinetobacter baumannii (CR-AB) clinical isolates recovered from patients...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056399/ https://www.ncbi.nlm.nih.gov/pubmed/30027698 http://dx.doi.org/10.3343/alm.2018.38.6.545 |
_version_ | 1783341325998882816 |
---|---|
author | Park, Yu Jin Hong, Duck Jin Yoon, Eun-Jeong Kim, Dokyun Choi, Min Hyuk Hong, Jun Sung Lee, Hyukmin Yong, Dongeun Jeong, Seok Hoon |
author_facet | Park, Yu Jin Hong, Duck Jin Yoon, Eun-Jeong Kim, Dokyun Choi, Min Hyuk Hong, Jun Sung Lee, Hyukmin Yong, Dongeun Jeong, Seok Hoon |
author_sort | Park, Yu Jin |
collection | PubMed |
description | BACKGROUND: The increasing morbidity and mortality rates associated with Acinetobacter baumannii are due to the emergence of drug resistance and the limited treatment options. We compared characteristics of colistin-resistant Acinetobacter baumannii (CR-AB) clinical isolates recovered from patients with and without prior colistin treatment. We assessed whether prior colistin treatment affects the resistance mechanism of CR-AB isolates, mortality rates, and clinical characteristics. Additionally, a proper method for identifying CR-AB was determined. METHODS: We collected 36 non-duplicate CR-AB clinical isolates resistant to colistin. Antimicrobial susceptibility testing, Sanger sequencing analysis, molecular typing, lipid A structure analysis, and in vitro synergy testing were performed. Eleven colistin-susceptible AB isolates were used as controls. RESULTS: Despite no differences in clinical characteristics between patients with and without prior colistin treatment, resistance-causing genetic mutations were more frequent in isolates from colistin-treated patients. Distinct mutations were overlooked via the Sanger sequencing method, perhaps because of a masking effect by the colistin-susceptible AB subpopulation of CR-AB isolates lacking genetic mutations. However, modified lipid A analysis revealed colistin resistance peaks, despite the population heterogeneity, and peak levels were significantly different between the groups. CONCLUSIONS: Although prior colistin use did not induce clinical or susceptibility differences, we demonstrated that identification of CR-AB by sequencing is insufficient. We propose that population heterogeneity has a masking effect, especially in colistin non-treated patients; therefore, accurate testing methods reflecting physiological alterations of the bacteria, such as phosphoethanolamine-modified lipid A identification by matrix-assisted laser desorption ionization-time of flight, should be employed. |
format | Online Article Text |
id | pubmed-6056399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Society for Laboratory Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-60563992018-11-01 Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment Park, Yu Jin Hong, Duck Jin Yoon, Eun-Jeong Kim, Dokyun Choi, Min Hyuk Hong, Jun Sung Lee, Hyukmin Yong, Dongeun Jeong, Seok Hoon Ann Lab Med Original Article BACKGROUND: The increasing morbidity and mortality rates associated with Acinetobacter baumannii are due to the emergence of drug resistance and the limited treatment options. We compared characteristics of colistin-resistant Acinetobacter baumannii (CR-AB) clinical isolates recovered from patients with and without prior colistin treatment. We assessed whether prior colistin treatment affects the resistance mechanism of CR-AB isolates, mortality rates, and clinical characteristics. Additionally, a proper method for identifying CR-AB was determined. METHODS: We collected 36 non-duplicate CR-AB clinical isolates resistant to colistin. Antimicrobial susceptibility testing, Sanger sequencing analysis, molecular typing, lipid A structure analysis, and in vitro synergy testing were performed. Eleven colistin-susceptible AB isolates were used as controls. RESULTS: Despite no differences in clinical characteristics between patients with and without prior colistin treatment, resistance-causing genetic mutations were more frequent in isolates from colistin-treated patients. Distinct mutations were overlooked via the Sanger sequencing method, perhaps because of a masking effect by the colistin-susceptible AB subpopulation of CR-AB isolates lacking genetic mutations. However, modified lipid A analysis revealed colistin resistance peaks, despite the population heterogeneity, and peak levels were significantly different between the groups. CONCLUSIONS: Although prior colistin use did not induce clinical or susceptibility differences, we demonstrated that identification of CR-AB by sequencing is insufficient. We propose that population heterogeneity has a masking effect, especially in colistin non-treated patients; therefore, accurate testing methods reflecting physiological alterations of the bacteria, such as phosphoethanolamine-modified lipid A identification by matrix-assisted laser desorption ionization-time of flight, should be employed. The Korean Society for Laboratory Medicine 2018-11 2018-07-18 /pmc/articles/PMC6056399/ /pubmed/30027698 http://dx.doi.org/10.3343/alm.2018.38.6.545 Text en © The Korean Society for Laboratory Medicine http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Park, Yu Jin Hong, Duck Jin Yoon, Eun-Jeong Kim, Dokyun Choi, Min Hyuk Hong, Jun Sung Lee, Hyukmin Yong, Dongeun Jeong, Seok Hoon Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment |
title | Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment |
title_full | Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment |
title_fullStr | Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment |
title_full_unstemmed | Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment |
title_short | Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment |
title_sort | differences in colistin-resistant acinetobacter baumannii clinical isolates between patients with and without prior colistin treatment |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056399/ https://www.ncbi.nlm.nih.gov/pubmed/30027698 http://dx.doi.org/10.3343/alm.2018.38.6.545 |
work_keys_str_mv | AT parkyujin differencesincolistinresistantacinetobacterbaumanniiclinicalisolatesbetweenpatientswithandwithoutpriorcolistintreatment AT hongduckjin differencesincolistinresistantacinetobacterbaumanniiclinicalisolatesbetweenpatientswithandwithoutpriorcolistintreatment AT yooneunjeong differencesincolistinresistantacinetobacterbaumanniiclinicalisolatesbetweenpatientswithandwithoutpriorcolistintreatment AT kimdokyun differencesincolistinresistantacinetobacterbaumanniiclinicalisolatesbetweenpatientswithandwithoutpriorcolistintreatment AT choiminhyuk differencesincolistinresistantacinetobacterbaumanniiclinicalisolatesbetweenpatientswithandwithoutpriorcolistintreatment AT hongjunsung differencesincolistinresistantacinetobacterbaumanniiclinicalisolatesbetweenpatientswithandwithoutpriorcolistintreatment AT leehyukmin differencesincolistinresistantacinetobacterbaumanniiclinicalisolatesbetweenpatientswithandwithoutpriorcolistintreatment AT yongdongeun differencesincolistinresistantacinetobacterbaumanniiclinicalisolatesbetweenpatientswithandwithoutpriorcolistintreatment AT jeongseokhoon differencesincolistinresistantacinetobacterbaumanniiclinicalisolatesbetweenpatientswithandwithoutpriorcolistintreatment |